Dudediligence.

Gilead Sciences, Inc

GILDNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 6 insiders sold $70.0M, 50 of 51 sales on a 10b5-1 plan.→HoldersBlackRock 9.8%Vanguard 6.5%FMR 5.4%→Financing →PeersClosest companies: INCY, BIIB, VRTX→

From the filings

Figures

Revenue
$30.46Blast 12 months
Net income
−$3.24Blast 12 months
Operating cash flow
$10.81Blast 12 months
Cash and equivalents
$3.18Bat the last balance sheet
Total debt
$26.25Bat the last balance sheet
Shares outstanding
1.24B shareson issue
Every year and quarter →